Get the Stockscreener App
41.34
1.29%
0.525
After Hours:
41.34
0.005
+0.01%
Lenz Therapeutics Inc stock is traded at $41.34, with a volume of 336.82K.
It is up +1.29% in the last 24 hours and up +13.78% over the past month.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.
See More
Previous Close:
$40.81
Open:
$40.82
24h Volume:
336.82K
Relative Volume:
0.72
Market Cap:
$1.18B
Revenue:
-
Net Income/Loss:
$-69.47M
P/E Ratio:
-7.3848
EPS:
-5.5973
Net Cash Flow:
$-73.92M
1W Performance:
-1.54%
1M Performance:
+13.78%
6M Performance:
+68.03%
1Y Performance:
+100.17%
1-Day Range:
$39.62
$41.61
1-Week Range:
$39.09
$42.77
52-Week Range:
$16.54
$42.77
Lenz Therapeutics Inc Stock (LENZ) Company Profile
Name
Lenz Therapeutics Inc
Sector
Industry
Phone
858-925-7000
Address
201 LOMAS SANTA FE DRIVE, SUITE 300, SOLANA BEACH
Compare LENZ with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LENZ
Lenz Therapeutics Inc
|
41.34 | 1.19B | 0 | -69.47M | -73.92M | -5.5973 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Lenz Therapeutics Inc Stock (LENZ) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-14-25 | Resumed | Piper Sandler | Overweight |
| Mar-18-25 | Initiated | TD Cowen | Buy |
| Sep-27-24 | Initiated | Raymond James | Outperform |
| Aug-12-24 | Initiated | H.C. Wainwright | Buy |
| Apr-15-24 | Initiated | Leerink Partners | Outperform |
| Apr-15-24 | Initiated | William Blair | Outperform |
| Apr-10-24 | Initiated | Citigroup | Buy |
| Mar-27-24 | Initiated | Piper Sandler | Overweight |
| Feb-23-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Feb-23-23 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Feb-23-23 | Downgrade | Cowen | Outperform → Market Perform |
| Jan-25-23 | Downgrade | BTIG Research | Buy → Neutral |
| Jan-18-23 | Downgrade | BofA Securities | Buy → Neutral |
| Jan-06-23 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Jan-06-23 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Sep-15-22 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-17-22 | Initiated | BMO Capital Markets | Outperform |
| Apr-14-22 | Initiated | BTIG Research | Buy |
| Mar-22-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Feb-18-22 | Initiated | RBC Capital Mkts | Sector Perform |
| Jul-20-21 | Initiated | Morgan Stanley | Overweight |
| Jul-20-21 | Initiated | SVB Leerink | Outperform |
View All
Lenz Therapeutics Inc Stock (LENZ) Latest News
Adage Capital Partners GP L.L.C. Makes New Investment in LENZ Therapeutics, Inc. $LENZ - MarketBeat
Chevallard Brings Financial Clarity to LENZ Therapeutics - San Diego Business Journal
LENZ Therapeutics, Inc. $LENZ Shares Bought by Granahan Investment Management LLC - MarketBeat
Trade Report: Is LENZ Therapeutics Inc. stock good for income investors2025 Technical Patterns & Free Weekly Chart Analysis and Trade Guides - Lancaster City Council
Can LENZ Therapeutics Inc. expand its profit marginsJuly 2025 Movers & Accurate Intraday Trade Tips - beatles.ru
Resistance Break Could Fuel LENZ Therapeutics Inc. RallyPortfolio Performance Report & Reliable Breakout Forecasts - beatles.ru
Aug Update: Can LENZ Therapeutics Inc. expand its profit marginsQuarterly Market Summary & Daily Stock Momentum Reports - 뉴스영
Scoggin Management LP Invests $2.57 Million in LENZ Therapeutics, Inc. $LENZ - MarketBeat
Backtesting results for LENZ Therapeutics Inc. trading strategiesJuly 2025 Price Swings & Verified Stock Trade Ideas - Newser
Real time social sentiment graph for LENZ Therapeutics Inc.July 2025 Levels & Proven Capital Preservation Tips - Newser
Can LENZ Therapeutics Inc. reach resistance levels soonPortfolio Return Report & Free Safe Entry Trade Signal Reports - خودرو بانک
Lenz Therapeutics stock hits 52-week high at 41.71 USD By Investing.com - Investing.com Canada
Earnings visualization tools for LENZ Therapeutics Inc.July 2025 Action & Weekly Setup with High ROI Potential - Newser
Is LENZ Therapeutics Inc. stock heavily shortedWeekly Stock Summary & AI Enhanced Trade Execution Alerts - خودرو بانک
Institutional scanner results for LENZ Therapeutics Inc.2025 AllTime Highs & High Accuracy Swing Trade Signals - Newser
Will LENZ Therapeutics Inc. stock go up soonLong Setup & Free Growth Oriented Trading Recommendations - Newser
Is LENZ Therapeutics Inc. exposed to currency risksPortfolio Gains Summary & Daily Stock Trend Watchlist - خودرو بانک
Lenz Therapeutics stock hits 52-week high at 41.71 USD - Investing.com
LENZ Therapeutics Inc. stock volume spike explained2025 AllTime Highs & High Conviction Trade Alerts - Newser
How much upside does LENZ Therapeutics Inc. haveExit Point & Real-Time Stock Movement Alerts - خودرو بانک
Multi factor analysis applied to LENZ Therapeutics Inc.IPO Watch & Real-Time Chart Pattern Alerts - Newser
AlphaQuest LLC Makes New $168,000 Investment in LENZ Therapeutics, Inc. $LENZ - MarketBeat
Investment Review: Will LENZ Therapeutics Inc. outperform during market ralliesJuly 2025 Analyst Calls & Weekly High Conviction Ideas - خودرو بانک
How to manage a losing position in LENZ Therapeutics Inc.Take Profit & Real-Time Chart Breakout Alerts - Newser
Does LENZ Therapeutics Inc. outperform in volatile marketsJuly 2025 Highlights & Entry and Exit Point Strategies - خودرو بانک
Tick level data insight on LENZ Therapeutics Inc. volatilityShort Setup & Daily Risk Controlled Trade Plans - Newser
What’s the beta of LENZ Therapeutics Inc. stockEarnings Risk Summary & Detailed Earnings Play Strategies - 더경남뉴스
What the charts say about LENZ Therapeutics Inc. todayJuly 2025 Price Swings & Reliable Breakout Stock Forecasts - Newser
Can volume confirm reversal in LENZ Therapeutics Inc.2025 Short Interest & Risk Adjusted Swing Trade Ideas - Newser
Lenz Therapeutics shares fall 1.17% premarket after presenting at Citi's Biopharma Back to School Conference. - AInvest
Analyzing LENZ Therapeutics Inc. with multi timeframe chartsJuly 2025 Trade Ideas & AI Enhanced Execution Alerts - Newser
Will LENZ Therapeutics Inc. price bounce be sustainableJuly 2025 Snapshot & AI Enhanced Market Trend Forecasts - Newser
Key metrics from LENZ Therapeutics Inc.’s quarterly data2025 Investor Takeaways & Technical Buy Zone Confirmation - Newser
Nuveen LLC Buys New Shares in LENZ Therapeutics, Inc. $LENZ - MarketBeat
What momentum shifts mean for LENZ Therapeutics Inc.July 2025 Pullbacks & Daily Stock Trend Watchlist - Newser
Trend analysis for LENZ Therapeutics Inc. this weekJuly 2025 Institutional & Technical Buy Zone Confirmation - Newser
What MACD signals say about LENZ Therapeutics Inc.July 2025 Weekly Recap & Reliable Intraday Trade Plans - Newser
Should you hold or exit LENZ Therapeutics Inc. nowJuly 2025 Chart Watch & Fast Entry High Yield Stock Tips - Newser
LENZ Therapeutics: A Case Study in Strategic Execution and Market Readiness - AInvest
Transcript : LENZ Therapeutics, Inc. Presents at Citi's Biopharma Back to School Conference, Sep-03-2025 09 - MarketScreener
Can swing trading help recover from LENZ Therapeutics Inc. lossesM&A Rumor & Safe Entry Zone Identification - Newser
Will LENZ Therapeutics Inc. rebound enough to break evenJuly 2025 Short Interest & AI Based Buy and Sell Signals - Newser
Relative strength of LENZ Therapeutics Inc. in sector analysisWeekly Gains Summary & High Win Rate Trade Alerts - Newser
Analyzing LENZ Therapeutics Inc. with risk reward ratio chartsPortfolio Growth Summary & Community Supported Trade Ideas - Newser
Will LENZ Therapeutics Inc. stock recover after recent dropIndex Update & Free Growth Oriented Trading Recommendations - Newser
Will LENZ Therapeutics Inc. outperform during market rallies2025 Volatility Report & Weekly Watchlist for Consistent Profits - خودرو بانک
Lenz Therapeutics Inc Stock (LENZ) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):